VALSARTAN RANBAXY

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

29-05-2024

इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।

सक्रिय संघटक:

VALSARTAN

थमां उपलब्ध:

Ranbaxy Ireland Limited

डोज़:

160 Milligram

फार्मास्यूटिकल फॉर्म:

Film Coated Tablet

प्राधिकरण की तारीख:

2011-10-21

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Valsartan Ranbaxy 160 mg film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 160 mg valsartan.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablets.
Pink coloured, film-coated, oval tablets debossed with ‘V &1’ on either side of breakline on one side and breakline on
the other side.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Hypertension
Treatment of essential hypertension in adults, and hypertension in children and adolescents 6 to 18 years of age.
Recent myocardial infarction
Treatment of clinically stable patients with symptomatic heart failure or asymptomatic left ventricular systolic
dysfunction after a recent (12 hours – 10 days) myocardial infarction (see sections 4.4 and 5.1).
Heart failure
Treatment of symptomatic heart failure when Angiotensin Converting Enzyme (ACE) inhibitors cannot be used, or as
add-on therapy to ACE inhibitors when beta blockers cannot be used (see sections 4.4 and 5.1).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_Posology_
Hypertension
The recommended starting dose of Valsartan Ranbaxy is 80 mg once daily. The antihypertensive effect is substantially
present within 2 weeks, and maximal effects are attained within 4 weeks. In some patients whose blood pressure is not
adequately controlled, the dose can be increased to 160 mg and to a maximum of 320 mg.
Valsartan Ranbaxy may also be administered with other antihypertensive agents. The addition of a diuretic such as
hydrochlorothiazide will decrease blood pressure even further in these patients.
Recent myocardial infarction
In clinically stable patients, therapy may be initiated as early as 12 hours after a

पूरा दस्तावेज़ पढ़ें

VALSARTAN RANBAXY

सक्रिय संघटक:

थमां उपलब्ध:

डोज़:

फार्मास्यूटिकल फॉर्म:

प्राधिकरण की तारीख:

उत्पाद विशेषताएं

इसी तरह के उत्पादों

सक्रिय संघटक

निर्माता या प्राधिकरण धारक

इस उत्पाद से संबंधित अलर्ट देखें

चेतावनियाँ

दस्तावेज़ इतिहास देखें

दस्तावेज़ इतिहास